Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.06.2018 | Case report

Cariprazine/oxycodone interaction

Worsening of fibromyalgia and chronic pain with decreased effectiveness of the oxycodone: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * Drug interaction
Literatur
Zurück zum Zitat Callahan M, et al. Worsening fibromyalgia and chronic pain induced by cariprazine, an atypical antipsychotic: A case report. Pain Medicine 19: 879-880 abstr. 236, No. 4, 1 Apr 2018. Available from: URL: https://doi.org/10.1093/pm/pny044 [abstract] - USA Callahan M, et al. Worsening fibromyalgia and chronic pain induced by cariprazine, an atypical antipsychotic: A case report. Pain Medicine 19: 879-880 abstr. 236, No. 4, 1 Apr 2018. Available from: URL: https://​doi.​org/​10.​1093/​pm/​pny044 [abstract] - USA
Metadaten
Titel
Cariprazine/oxycodone interaction
Worsening of fibromyalgia and chronic pain with decreased effectiveness of the oxycodone: case report
Publikationsdatum
01.06.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-47892-9

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Rituximab

Case report

Zopiclone

Case report

Docetaxel